New trial recruiting PV and ET patients

August 2013

Incyte Corp. has announced two new trials that are currently recruiting ET and PV patients:

According to representatives from Incyte, the RELIEF trial is designed to understand better and measure how ruxolitinib treats the burden of symptoms reported by PV patients taking Hydroxyurea. Reported symptoms include tiredness, itching, muscle aches, and night sweats. Dr. Ruben Mesa recently recorded a video discussing PV and these trials in particular. Click here to watch the video.

For information on either trials, visit You can also learn more via the Incyte clinical trials hotline: 877-4-PV-Trial (877-478-8742) or


Receive updates on the latest MPN news & events.

Find out ways you can help support MPN patients and researchers.



Get free, timely information on living with an MPN.